104 related articles for article (PubMed ID: 3105628)
1. [Current role of chemotherapy in the treatment of adenocarcinomas of the endometrium].
Chauvergne J; Avril A; Pigneux J; Mage P; Granger C
Bull Cancer; 1986; 73(6):675-9. PubMed ID: 3105628
[No Abstract] [Full Text] [Related]
2. [Palliative chemotherapy of endometrial cancer. Value of combinations with doxorubicin and cisplatin].
Chauvergne J; Granger C; Mage P; Pigneux J; David M
Rev Fr Gynecol Obstet; 1986 Oct; 81(10):547-51. PubMed ID: 2431448
[TBL] [Abstract][Full Text] [Related]
3. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
4. The application of dose intensity to problems in chemotherapy of ovarian and endometrial cancer.
Levin L; Hryniuk W
Semin Oncol; 1987 Dec; 14(4 Suppl 4):12-9. PubMed ID: 3120317
[TBL] [Abstract][Full Text] [Related]
5. [High-dose chemotherapy in ovarian adenocarcinoma].
Lotz JP; Lhommé C; Pautier P; Couteau C; Gligorov J; Alexandre J; Selle F; Izrael V; Maraninchi D; Viens P
Bull Cancer; 2000 Jan; 87(1):63-9. PubMed ID: 10673633
[No Abstract] [Full Text] [Related]
6. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
7. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
Turbow MM; Ballon SC; Sikic BI; Koretz MM
Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy in advanced forms of carcinoma of the ovary].
Calciati A; Clerico M; Donadio M; Giaccone G
Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of epithelial ovarian carcinoma].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
[No Abstract] [Full Text] [Related]
11. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
12. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
[No Abstract] [Full Text] [Related]
13. [Chemotherapy and endocrine therapy of endometrial carcinoma].
Kanuma T; Matsuzawa M
Gan No Rinsho; 1990 Aug; 36(10):1161-5. PubMed ID: 2214155
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
Senapad S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
[No Abstract] [Full Text] [Related]
15. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Piver MS; Lele S; Barlow JJ
Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and cisplatin in the treatment of advanced mixed mesodermal uterine sarcoma.
Seltzer V; Kaplan B; Vogl S; Spitzer M
Cancer Treat Rep; 1984 Nov; 68(11):1389-90. PubMed ID: 6541972
[No Abstract] [Full Text] [Related]
17. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
Ohara N; Teramoto K; Murao S
J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
[No Abstract] [Full Text] [Related]
19. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]